Evidence map›Paper›PMID 41552550›Full record

ArticleACS omega2026

[

Xiaoqing Zhuang, Jonne Kunnas, David Ekwe, Emel Bakay, Pyry Dillemuth, Heidi Liljenbäck, Imran Iqbal, Johan Rajander, Philip S Low, Juhani Knuuti and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaoqing ZhuangTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Jonne KunnasTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.ORCID https://orcid.org/0000-0001-9663-1461
David EkweTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Emel BakayTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Pyry DillemuthTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Heidi LiljenbäckTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.ORCID https://orcid.org/0000-0001-9372-1584
Imran IqbalTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.ORCID https://orcid.org/0000-0002-9554-5905
Johan RajanderTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.ORCID https://orcid.org/0000-0003-3591-0963
Philip S LowDepartment of Chemistry, Purdue University, 560 Oval Drive, West Lafayatte, Indiana 47907-2084, United States.ORCID https://orcid.org/0000-0001-9042-5528
Juhani KnuutiTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Jessica M RosenholmPharmaceutical Sciences Laboratory, Department of Natural and Health Sciences, Faculty of Science and Engineering, Åbo Akademi University, Tykistökatu 6A, FI-20521 Turku, Finland.ORCID https://orcid.org/0000-0001-6085-1112
Antti SarasteTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Anne RoivainenTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Xiang-Guo LiTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.ORCID https://orcid.org/0000-0002-9118-7223

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Folate receptors are clinically relevant targets, as evidenced by therapeutic agents, including mirvetuximab soravtansine-gynx, an antibody-drug conjugate recently approved for cancer treatment. In this study, we report the development of a novel positron emission tomography (PET) imaging agent, [

Identifiers

PMID41552550
PMCPMC12809762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.